Cardiovascular Health Supplements Market Report 2026

The cardiovascular health supplements market size has grown rapidly in recent years. It will grow from $14.62 billion in 2025 to $16.38 billion in 2026 at a compound annual growth rate (CAGR) of 12%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, increasing consumer health awareness, growth in dietary supplement consumption, expansion of retail and pharmacy distribution networks, increased adoption of preventive healthcare practices.

The cardiovascular health supplements market size is expected to see rapid growth in the next few years. It will grow to $25.76 billion in 2030 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to aging population worldwide, rising lifestyle-related health risks, growing interest in self-managed health solutions, expansion of e-commerce supplement sales, increasing focus on heart health among younger consumers. Major trends in the forecast period include growing preventive approach toward cardiovascular health, increasing consumer preference for daily heart health supplements, rising demand for natural and plant-based cardiovascular supplements, expansion of over-the-counter cardiovascular wellness products, increased focus on clinically backed supplement formulations.

The rising incidence of cardiovascular diseases is anticipated to fuel expansion in the cardiovascular health supplements market. Cardiovascular diseases (CVDs), which impact the heart and blood vessels, encompass conditions such as hypertension, coronary artery disease, and heart failure. Their prevalence is climbing due to poor diets, lack of exercise, tobacco use, and ongoing stress. The cardiovascular health supplements market aids heart performance by delivering key nutrients and components that promote cardiovascular wellness and assist those managing heart conditions. For instance, in September 2024, data from the Minnesota Department of Health, a US state health agency, revealed that about 30% of Minnesota adults suffered from high blood pressure in 2023 - affecting nearly 1.4 million individuals - and in 2022, hypertension-related illnesses led to 14,225 deaths, accounting for 28% of the state's total fatalities. Thus, the growing burden of heart-related diseases is propelling the cardiovascular health supplements market.

Major companies in the cardiovascular health supplements market are prioritizing the development of innovative natural, plant-based products, like dispersible phytosterol formulations, to enhance cholesterol control and bolster their market edge. Dispersible phytosterols are water-soluble plant sterols designed for easy dispersion in liquids, which boosts their absorption and effectively lowers cholesterol uptake in the intestines, promoting heart and metabolic well-being. For example, in September 2023, Nutrartis - a Chile-based provider of health solutions - introduced Cardiosmile, a liquid supplement featuring water-dispersible natural plant sterols that aids daily heart health by curbing cholesterol absorption, delivering evidence-based advantages for sustaining optimal cholesterol levels and advancing comprehensive cardiovascular health.

In September 2023, Sanofi, a French pharmaceutical company, bought Qunol for an undisclosed sum. This deal bolsters Sanofi’s consumer healthcare lineup by growing its footprint in the rapidly expanding vitamins, minerals, and supplements (VMS) market in the United States. It also improves Sanofi’s capacity to meet the needs of an aging demographic with popular cardiovascular health supplements via Qunol’s well-known brand and products. Qunol is a U.S.-based firm focused on cardiovascular health supplements.

Major companies operating in the cardiovascular health supplements market are Pfizer Inc., Johnson & Johnson, Amway Corporation, Herbalife Nutrition Ltd., General Nutrition Centers Inc. (GNC), NOW Health Group Inc., Garden of Life LLC, Thorne Healthtech Inc., Jarrow Formulas Inc., Life Extension, Designs for Health Inc., Gaia Herbs Inc., Schiff Nutrition International, MegaFood LLC, Twinlab Consolidated Holdings Inc., New Chapter Inc., Integrative Therapeutics LLC, Pure Encapsulations LLC, Doctor's Best Inc., Nature's Bounty Co., Solgar Inc., Nature Made Nutritional Products.

Asia-Pacific was the largest region in the cardiovascular health supplements market in 2025. The regions covered in the cardiovascular health supplements market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular health supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the cardiovascular health supplements market by increasing costs of imported raw materials such as omega fatty acids, botanical extracts, and synthetic ingredients used in supplement formulations. These impacts are most visible across natural supplement and omega fatty acid segments, particularly in regions dependent on global ingredient sourcing including north america, europe, and asia-pacific. At the same time, tariffs have encouraged local sourcing, domestic manufacturing, and supplier diversification, strengthening supply chain resilience and regional production capabilities.

The cardiovascular health supplements market research report is one of a series of new reports that provides cardiovascular health supplements market statistics, including cardiovascular health supplements industry global market size, regional shares, competitors with a cardiovascular health supplements market share, detailed cardiovascular health supplements market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular health supplements industry. This cardiovascular health supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cardiovascular health supplements consist of dietary products designed to promote the health and performance of the heart and blood vessels. These supplements are frequently taken to bolster heart health and help prevent or address diverse cardiovascular issues.

The primary categories of cardiovascular health supplements consist of natural supplements and synthetic supplements. Natural supplements come from natural origins like plants, animals, and minerals. They feature ingredients such as vitamins and minerals, herbs and botanicals, omega fatty acids, coenzyme Q10 (CoQ10), and others, offered in forms including liquids, tablets, capsules, softgels, powders, and more. These are distributed through channels like offline and online options.

The cardiovascular health supplements market consists of sales of fiber supplements, garlic supplements, and magnesium. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.